IS2775B - Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra - Google Patents

Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra

Info

Publication number: IS2775B
Authority: IS; Iceland
Prior art keywords: pyrrolocarbazole; synthesized; production methods; production; methods
Prior art date: 2003-12-23

Application number

IS8520A

Other languages

English (en)

Other versions

IS8520A (is

Inventor

Robert L Hudkins

Dandu R Reddy

Ming Tao

Theodore L Underiner

Allison L Zulli

Original Assignee

Cephalon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-23

Filing date

2006-06-22

Publication date

2012-03-15

2006-06-22 Application filed by Cephalon Inc filed Critical Cephalon Inc

2006-06-22 Publication of IS8520A publication Critical patent/IS8520A/is

2012-03-15 Publication of IS2775B publication Critical patent/IS2775B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
- C09B57/08—Naphthalimide dyes; Phthalimide dyes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
Vascular Medicine (AREA)

IS8520A 2003-12-23 2006-06-22 Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra IS2775B (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US53225203P	2003-12-23	2003-12-23
US11/017,915 US7241779B2 (en)	2003-12-23	2004-12-22	Fused pyrrolocarbazoles
PCT/US2004/043164 WO2005063764A2 (en)	2003-12-23	2004-12-23	Fused pyrrolocarbazoles and methods for the preparation thereof

Publications (2)

Publication Number	Publication Date
IS8520A IS8520A (is)	2006-06-22
IS2775B true IS2775B (is)	2012-03-15

Family

ID=34680997

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8520A IS2775B (is)	2003-12-23	2006-06-22	Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra

Country Status (21)

Country	Link
US (3)	US7241779B2 (is)
EP (2)	EP2088150B1 (is)
JP (1)	JP5006047B2 (is)
KR (2)	KR20060126738A (is)
CN (2)	CN104788459A (is)
AR (1)	AR048808A1 (is)
AT (1)	ATE433453T1 (is)
AU (1)	AU2004309397B2 (is)
BR (1)	BRPI0418120A (is)
CA (1)	CA2549628C (is)
DE (1)	DE602004021508D1 (is)
EA (1)	EA013182B1 (is)
ES (2)	ES2326225T3 (is)
IL (1)	IL176385A (is)
IS (1)	IS2775B (is)
MY (2)	MY149041A (is)
NO (2)	NO336892B1 (is)
NZ (1)	NZ586306A (is)
SG (1)	SG149042A1 (is)
TW (1)	TWI342309B (is)
WO (1)	WO2005063764A2 (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060276497A1 (en) *	2000-05-09	2006-12-07	Cephalon, Inc.	Novel multicyclic compounds and the use thereof
US7241779B2 (en) *	2003-12-23	2007-07-10	Cephalon, Inc.	Fused pyrrolocarbazoles
US7169802B2 (en) *	2003-12-23	2007-01-30	Cephalon, Inc.	Fused pyrrolocarbazoles
US20060058250A1 (en) *	2004-09-10	2006-03-16	Cephalon, Inc.	Methods of treating proliferative skin diseases using carbazole derivatives
KR101346907B1 (ko) *	2005-04-14	2014-01-02	메르크 파텐트 게엠베하	유기 전자 소자용 화합물
WO2007002670A2 (en) *	2005-06-28	2007-01-04	Bausch & Lomb Incorporated	Method of lowering intraocular pressure
EP2167075A4 (en) *	2007-06-08	2012-07-11	Univ Massachusetts	MIXED LINEAGE KINASES AND METABOLISM DISORDER
TWI468417B (zh)	2007-11-30	2015-01-11	Genentech Inc	抗－ｖｅｇｆ抗體
EP2242367A4 (en) *	2008-01-08	2012-07-04	Univ Pennsylvania	Rel inhibitors and methods of use thereof
CA2729012A1 (en)	2008-06-27	2009-12-30	Amgen Inc.	Ang-2 inhibition to treat multiple sclerosis
CA2741089A1 (en)	2008-10-22	2010-04-29	Genentech, Inc.	Modulation of axon degeneration
AU2015202365B2 (en) *	2008-10-22	2016-11-24	Genentech, Inc.	Modulation of axon degeneration
AU2009316600B2 (en) *	2008-11-19	2015-09-24	Cephalon, Inc.	Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound
RU2012120783A (ru) *	2009-10-22	2013-11-27	Женентек, Инк.	Модуляция дегенерации аксона
JP5922223B2 (ja) *	2011-04-13	2016-05-24	メルクパテントゲーエムベーハー	電子デバイス用化合物
IN2014CN02036A (is) *	2011-09-21	2015-05-29	Givaudan Sa
BR112015020063A2 (pt) *	2013-02-28	2017-08-29	Genentech Inc	Métodos de redução da estabilidade de quinase, de redução ou inibição da fosforilação, de inibição ou prevenção da degeneração neuronal e de detecção da atividade de dlk pró-apoptótica
US9029565B1 (en) *	2013-11-20	2015-05-12	Transitions Optical, Inc.	Fused ring indeno compounds for preparation of photochromic compounds
MX372919B (es) *	2015-04-21	2020-04-27	Jiangsu Hengrui Medicine Co	Derivado de imidazol-isoindol, su metodo de preparacion y su uso medico.
KR102537804B1 (ko)	2018-06-06	2023-05-31	미쓰비시덴키 가부시키가이샤	프로세스 버스 적용 보호 시스템 및 인텔리전트 전자 디바이스

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ245203A (en) *	1991-11-29	1997-07-27	Banyu Pharma Co Ltd	5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5594009A (en)	1994-10-14	1997-01-14	Cephalon, Inc.	Fused pyrrolocarbazoles
US5705511A (en)	1994-10-14	1998-01-06	Cephalon, Inc.	Fused pyrrolocarbazoles
US5475110A (en)	1994-10-14	1995-12-12	Cephalon, Inc.	Fused Pyrrolocarbazoles
US5591855A (en)	1994-10-14	1997-01-07	Cephalon, Inc.	Fused pyrrolocarbazoles
US5616724A (en)	1996-02-21	1997-04-01	Cephalon, Inc.	Fused pyrrolo[2,3-c]carbazole-6-ones
AU710669B2 (en)	1996-08-22	1999-09-23	Bristol-Myers Squibb Company	Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
US6127401A (en) *	1998-06-05	2000-10-03	Cephalon, Inc.	Bridged indenopyrrolocarbazoles
US6200968B1 (en) *	1998-08-06	2001-03-13	Cephalon, Inc.	Particle-forming compositions containing fused pyrrolocarbazoles
US6841567B1 (en)	1999-02-12	2005-01-11	Cephalon, Inc.	Cyclic substituted fused pyrrolocarbazoles and isoindolones
US6630500B2 (en)	2000-08-25	2003-10-07	Cephalon, Inc.	Selected fused pyrrolocarbazoles
AU2001292579A1 (en)	2000-09-29	2002-04-15	Eli Lilly And Company	Methods and compounds for treating proliferative diseases
US6610727B2 (en)	2000-10-06	2003-08-26	Bristol-Myers Squibb Company	Anhydro sugar derivatives of indolocarbazoles
US6653290B2 (en)	2000-10-06	2003-11-25	Bristol-Myers Squibb Company	Tumor proliferation inhibitors
US6558420B2 (en)	2000-12-12	2003-05-06	Bausch & Lomb Incorporated	Durable flexible attachment components for accommodating intraocular lens
US7018999B2 (en)	2001-05-16	2006-03-28	Cephalon, Inc.	Methods for the treatment and prevention of pain
WO2005045195A2 (en)	2003-10-28	2005-05-19	Daniel Warren	Method for preparing in-ground tunnel structures
US7169802B2 (en) *	2003-12-23	2007-01-30	Cephalon, Inc.	Fused pyrrolocarbazoles
US7241779B2 (en)	2003-12-23	2007-07-10	Cephalon, Inc.	Fused pyrrolocarbazoles

2004
- 2004-12-22 US US11/017,915 patent/US7241779B2/en not_active Expired - Lifetime
- 2004-12-23 EP EP09075214A patent/EP2088150B1/en not_active Expired - Lifetime
- 2004-12-23 TW TW093140223A patent/TWI342309B/zh not_active IP Right Cessation
- 2004-12-23 CN CN201510129906.8A patent/CN104788459A/zh active Pending
- 2004-12-23 BR BRPI0418120-4A patent/BRPI0418120A/pt not_active Application Discontinuation
- 2004-12-23 MY MYPI20085251A patent/MY149041A/en unknown
- 2004-12-23 AT AT04820922T patent/ATE433453T1/de not_active IP Right Cessation
- 2004-12-23 ES ES04820922T patent/ES2326225T3/es not_active Expired - Lifetime
- 2004-12-23 EP EP04820922A patent/EP1711499B1/en not_active Expired - Lifetime
- 2004-12-23 EA EA200601219A patent/EA013182B1/ru not_active IP Right Cessation
- 2004-12-23 CN CN201510655573.2A patent/CN105294702A/zh active Pending
- 2004-12-23 MY MYPI20045330A patent/MY142713A/en unknown
- 2004-12-23 WO PCT/US2004/043164 patent/WO2005063764A2/en not_active Ceased
- 2004-12-23 KR KR1020067014797A patent/KR20060126738A/ko not_active Ceased
- 2004-12-23 DE DE602004021508T patent/DE602004021508D1/de not_active Expired - Lifetime
- 2004-12-23 CA CA2549628A patent/CA2549628C/en not_active Expired - Fee Related
- 2004-12-23 AU AU2004309397A patent/AU2004309397B2/en not_active Ceased
- 2004-12-23 SG SG200809397-3A patent/SG149042A1/en unknown
- 2004-12-23 KR KR1020127011222A patent/KR101268704B1/ko not_active Expired - Fee Related
- 2004-12-23 JP JP2006547325A patent/JP5006047B2/ja not_active Expired - Lifetime
- 2004-12-23 ES ES09075214T patent/ES2387596T3/es not_active Expired - Lifetime
- 2004-12-23 NZ NZ586306A patent/NZ586306A/en not_active IP Right Cessation
- 2004-12-27 AR ARP040104891A patent/AR048808A1/es not_active Application Discontinuation
2006
- 2006-06-18 IL IL176385A patent/IL176385A/en active IP Right Grant
- 2006-06-22 IS IS8520A patent/IS2775B/is unknown
- 2006-07-10 NO NO20063193A patent/NO336892B1/no not_active IP Right Cessation
2007
- 2007-05-03 US US11/744,030 patent/US7514440B2/en not_active Expired - Lifetime
2009
- 2009-03-31 US US12/415,525 patent/US8084472B2/en not_active Expired - Lifetime
2015
- 2015-09-23 NO NO20151246A patent/NO338804B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2326225T3 (es)	2009-10-05
CN105294702A (zh)	2016-02-03
HK1137439A1 (en)	2010-07-30
AU2004309397B2 (en)	2011-05-19
KR20060126738A (ko)	2006-12-08
IS8520A (is)	2006-06-22
BRPI0418120A (pt)	2007-04-27
CN104788459A (zh)	2015-07-22
JP2007526909A (ja)	2007-09-20
US20090186888A1 (en)	2009-07-23
DE602004021508D1 (de)	2009-07-23
NO20063193L (no)	2006-09-15
KR20120065433A (ko)	2012-06-20
MY142713A (en)	2010-12-31
IL176385A (en)	2014-02-27
US8084472B2 (en)	2011-12-27
EP1711499A2 (en)	2006-10-18
IL176385A0 (en)	2006-10-05
SG149042A1 (en)	2009-01-29
NO338804B1 (no)	2016-10-24
ES2387596T3 (es)	2012-09-26
CA2549628C (en)	2012-12-11
US7514440B2 (en)	2009-04-07
EA200601219A1 (ru)	2006-12-29
AR048808A1 (es)	2006-05-31
US7241779B2 (en)	2007-07-10
TWI342309B (en)	2011-05-21
NO20151246L (no)	2006-09-15
CA2549628A1 (en)	2005-07-14
KR101268704B1 (ko)	2013-05-28
EP2088150B1 (en)	2012-06-06
EP1711499B1 (en)	2009-06-10
EP2088150A1 (en)	2009-08-12
WO2005063764A3 (en)	2005-08-25
ATE433453T1 (de)	2009-06-15
AU2004309397A1 (en)	2005-07-14
US20050137245A1 (en)	2005-06-23
US20070203135A1 (en)	2007-08-30
WO2005063764A2 (en)	2005-07-14
JP5006047B2 (ja)	2012-08-22
MY149041A (en)	2013-07-15
NZ586306A (en)	2011-12-22
NO336892B1 (no)	2015-11-23
EA013182B1 (ru)	2010-02-26
HK1096394A1 (en)	2007-06-01
TW200530244A (en)	2005-09-16

Publication	Publication Date	Title
IS8520A (is)	2006-06-22	Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra
NO20031776D0 (no)	2003-04-16	Null-boringskomplettering og produksjonssystem
DE60324888D1 (de)	2009-01-08	und Herstellungsverfahren
NO20032220D0 (no)	2003-05-15	Löfteverktöy II og fremgangsmåte for anvendelse av samme
IS8305A (is)	2006-02-16	Bindandi smíðar og aðferðir við notkun þeirra
DK1465615T3 (da)	2012-11-12	Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
DK1591446T3 (da)	2013-06-10	Thienopyrimidinforbindelser og anvendelse deraf.
IL176089A0 (en)	2006-10-05	Modified macromolecules and methods of making and using thereof
NO20055211D0 (no)	2005-11-04	Anti-fungale forbindelser og fremgangsmater for anvendelse
IS7467A (is)	2004-09-23	Lansóprasólfjölgervingar og aðferðir við að framleiða þá
ATE512148T1 (de)	2011-06-15	Pyrazolo- und imidazopyrimidinderivate
DK1771421T3 (da)	2009-07-13	N-hydroxyamidderivater og anvendelse deraf
PL1743076T5 (pl)	2024-07-15	Elementy akustyczne i ich wytwarzanie
NO20054095D0 (no)	2005-09-02	Pyridyloksymetyl og benzioksazolazabicyklisk derivater
EP1639096A4 (en)	2007-09-05	PROCESS FOR THE PRODUCTION OF NEURONES
DE60302757D1 (de)	2006-01-19	Kleinfahrzeug
IS7980A (is)	2005-08-12	Díarýlmetýlídenpíperidínafleiður, framleiðsla þeirra og notkun
IS8489A (is)	2006-05-26	Umritunarstillar og aðferðir þeirra
DE60322747D1 (de)	2008-09-18	Planare mehrkeulenantenne und herstellungsverfahren
DK1408059T3 (da)	2014-07-28	Latex og fremstilling heraf
DE602004030793D1 (de)	2011-02-10	Asynchrones flimmerreduktionsverfahren
NO20041050L (no)	2004-09-15	Fremgmgsmate og sammensetninger
FR2858986B3 (fr)	2005-07-22	Tamis
FI20030130A0 (fi)	2003-01-29	Seulontamenetelmä
ATA20092003A (de)	2005-10-15	Schmuckstein